Where does ChromaDex Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ChromaDex Inc. ranks #16,685 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ChromaDex Inc. hold?

ChromaDex Inc. holds 17 US utility patents granted between 2018 and 2025, spanning 8 technology areas.

What is ChromaDex Inc.'s Innovation Score?

ChromaDex Inc. has an Innovation Score of 37.7 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ChromaDex Inc. focus on?

ChromaDex Inc.'s top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 11 patents, ranking #78 of 896 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is ChromaDex Inc.'s patent grant rate increasing or decreasing?

ChromaDex Inc.'s recent grant velocity is +120% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ChromaDex Inc.'s patents?

ChromaDex Inc.'s patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ChromaDex Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ChromaDex Inc.

USPTO PatentsView assignee record - 17 granted patents across 8 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chromadex ranks #16,685 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 8 technology areas.

#16,685
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 20.0
avg claims per patent: +120%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16685 · US Corporation #16,685 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,685/49,997
PHOTO-FINISH Chi Hua Fitness
CPC-NARROW C07H · 8 areas
INNOV-THIN 37.7/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +120% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chi Hua Fitness Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chromadex’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (27%) Velocity 5.7 pts (15%) Breadth 10.0 pts (27%) Claim depth 12.0 pts (32%)

Qualcomm Incorporated · highest

85
ChromaDex · this assignee

38
3D Lighting… · lowest

7

What this shows Chromadex's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Chromadex?

Each dot is one of Chromadex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chromadex’s own 20.0 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Chromadex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chromadex's grants concentrate

ChromaDex Inc. is a focused PatentsView assignee: 8 CPC subclasses with 64.7% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2023. By volume, Chromadex sits between Chi Hua Fitness Co., Ltd. and CoLabs International Corporation.

Chromadex's three-year grant acceleration

ChromaDex Inc. shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Chi Hua Fitness

17
China Pacificarbi…

17
Choice Spine

17
Chr Hansen HMO

17
Ciambella

17
Clayton

17
Cloudparc

17
Colabs Internatio…

17
Chromadex ◀

17

What this shows ChromaDex holds 17 patents at rank #16,699, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ChromaDex

By rank, the assignees closest to #16,699 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in ChromaDex's primary technology class.

Chromadex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

ChromaDex Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	17.6%
2019	2	11.8%
2020	3	17.6%
2021	2	11.8%
2022	5	29.4%
2023	1	5.9%
2025partial year	1	5.9%

Which technologies does ChromaDex Inc. patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 11

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C07D - Heterocyclic Compounds 7

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ChromaDex Inc.'s patent record in context - here's where to go next.

ChromaDex Inc.'s lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 64.7% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #16,685 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ChromaDex Inc. against Chi Hua Fitness Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.